Active, not recruiting
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
NCT05689879
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
- Locations
-
- Hôpital de la Pitié-Salpêtrière Paris, France